As reported in a recent article in the New York Times, researchers from the National Cancer Institute have developed an immune system treatment for a woman afflicted with cholangiocarcinoma (bile-duct cancer) utilizing her own stem cells. The scientists, led by Dr. Steven A Rosenberg, identified T-cells in the woman’s immune system that specifically attacked the cancerous cells in her body. They then used her stem cells to grow billions of these T-cells in a laboratory, and then infused the T-cells back into her bloodstream. After 18 months of the treatment, known as adoptive cell therapy, the woman experienced considerable reduction of tumor size and quantity.
Common tumors, such as those caused by cholangiocarcinoma, are responsible for 80% of the 580,000 cancer deaths in the United States. The use of autologous [the patient’s own] stem cells in adoptive cell therapy marks a significant advance in both cancer treatment and regenerative medicine, which can potentially lead to new, more effective and less invasive treatment options for cancer patients.
This research is yet another example of how autologous [a patient’s own] stem cells are influencing the outcome of treatment options. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.